Presentations – Artrya

Our Solution
- Physicians
- Patients
About Artrya
Investor Relations
Contact Us

Request a demonstration

2025 March 31 ASX FDA Clearance

2025 Feb Capital Raising

2024 Nov 28 Chairman CEO AGM Presentation

Precise diagnosis. Personalized treatment.
Preventative care.

Choose Artrya as your trusted clinical partner.

Contact us today

Coronary artery disease.

We see you.

Sign up to our newsletter

Request a Demo
Contact Us

About Artrya
Investor Relations

Location

1257 Hay Street, West Perth, 6005

X

Salix Coronary Anatomy is listed on the Australian Register of Therapeutic Goods, ID 347719. Salix Central USA product (K243038) is cleared in the USA. For the availability of Salix in The EU, UK, or other jurisdictions, please contact us.